Results 81 to 90 of about 7,522 (217)
Use of MRI in the diagnosis of bladder cancer: a health economic analysis
BJU International, EarlyView.
Niranjan Sathianathen +4 more
wiley +1 more source
INtraVESical immunoTherapy (INVEST) prior to radical cystectomy for bladder cancer: trial protocol
Background High‐risk non‐muscle‐invasive bladder cancer (HRNMIBC) has a variable prognosis, managed predominantly by local surgical resection and intravesical Bacillus Calmette–Guérin (BCG), or radical cystectomy (RC). Current treatments are poorly tolerated, have supply limitations and often fail to control the disease.
Ruby Lister‐Whelan +13 more
wiley +1 more source
Simultaneous TURP and TURBT Is Oncologically Safe
Background: Bladder cancer (BC) and benign prostatic hyperplasia (BPH) commonly coexist in elderly men, often necessitating transurethral resection of bladder tumor (TURBT) and transurethral resection of the prostate (TURP). Concerns have historically existed regarding the oncological safety of performing both procedures simultaneously, particularly ...
Mozzammel Haque +5 more
openaire +1 more source
BT, bladder tumor; TURBT, transurethral resection of bladder tumor; BCG, bacillus Calmette-Guérin; BN, bladder neck; CIS, carcinoma in situ.
Taekmin Kwon (605718) +6 more
core +1 more source
Background: To develop a bleeding simulator for transurethral resection of bladder tumors (TURBT) and evaluate its use as a training tool. Methods: Anatomical models of the human bladder and relevant structures were created with poly-vinyl alcohol ...
Ahmed Ghazi +5 more
core +1 more source
Objectives To review how response to neoadjuvant therapy (NAT) is assessed in clinical trials of muscle‐invasive bladder cancer (MIBC), and to determine whether trial‐derived evidence can inform response evaluation in contemporary practice. Subjects/Patients and Methods We searched PubMed, Embase and ClinicalTrials.gov through August 2025 for ...
Roberto Contieri +9 more
wiley +1 more source
Objective To evaluate the impact of transurethral resection of the bladder tumour (TURBT) on the release of circulating tumour cells (CTCs) in patients suspected of having muscle-invasive bladder cancer (MIBC) and to assess metastasis in follow-up ...
Gerald W. Verhaegh +7 more
doaj +1 more source
Holmium laser transurethral resection of bladder tumor: Our experience
Purpose: To compare the safety and efficiency of conventional monopolar and holmium laser en bloc transurethral resection of bladder tumor (CM-TURBT and HoL-EBRBT) while managing primary nonmuscle-invasive bladder cancer.
Nischith D'souza, Ashish Verma
doaj +1 more source
Trends in kidney stone disease: a 5‐year update of stone management in England and Scotland
Objectives To describe contemporary trends in kidney stone disease (KSD)‐related inpatient episodes, procedures, and costs in England and Scotland, with emphasis on post‐coronavirus disease 2019 (COVID‐19) service recovery, socioeconomic variation in Scotland, comparison with other urological procedures, and 10‐year healthcare demand and cost ...
Catherine E. Lovegrove +4 more
wiley +1 more source
The impact of preoperative venous thromboembolism on patients undergoing TURBT: Perioperative outcomes and healthcare costs from US insurance claims data [PDF]
Objectives: To assess the impact of a positive history of venous thromboembolism (VTE) on perioperative outcomes, including length of in-hospital stay, readmission rates, 90-day postoperative complications, and healthcare costs in bladder cancer (BCa ...
Challacombe, Benjamin +49 more
core +1 more source

